All News
The human metapneumovirus hype and India’s stock market tumble
Dr Abdul Ghafur highlights how media narratives, public perception, and investor behaviour intersected during the HMPV scare, affecting market dynamics
Read MoreHow Lagging Vaccination Could Lead to a Polio Resurgence
In its original form, the virus survives in just two countries. But a type linked to an oral vaccine used in other nations has already turned up in the West.
Read MoreEven Adults May Soon Be Vulnerable to ‘Childhood’ Diseases
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may be vulnerable to some illnesses.
Read MoreAt This Ballet Company, the Priority Is Dancers’ Mental Health
Azara Ballet in Florida is a place where performers can just be themselves.
Read MoreCan Medical Schools Funnel More Doctors Into the Primary Care Pipeline?
More medical schools say they will no longer charge tuition, in hopes that more students, graduating free of debt, will choose lower-paying primary care careers.
Read MoreTrump’s Return Puts Medicaid on the Chopping Block
Republicans in Washington are working on plans to shrink Medicaid, the nearly $900-billion-a-year government health insurance program that covers 1 in 5 Americans.
Read MoreSTAT+: Cigna, Centene, Walgreens drop out of J.P. Morgan conference
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
Read MoreKetamine’s move from club to ‘chill out’ drug is sign of a troubling culture shift
Experts say mental health treatment is key to tackling rise in UK, rather than simply reclassifying drug as class AIt was once viewed as a fringe club drug whose use as a horse tranquilliser gave it a
Read MoreSTAT+: ‘My life’s purpose’: A neuroscientist wants to rewire mental illness treatment and remake the field he loves
Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, depression, bipolar disorder, and schizophrenia.
Read MoreUniversity of Sheffield leads trial on device for stroke-related arm weakness
Sheffield researchers test nerve-stimulating device to improve arm function in stroke survivors
Read More